Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: A randomized multicenter study
Authors:
- Kamil KarolczakKKKamil Karolczak
- Wojciech KamyszWKWojciech Kamysz
- Anna KarafovaAKAnna Karafova
- Jozef DrzewoskiJDJozef Drzewoski
- Cezary WatalaCWCezary Watala
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 74, 7-22
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Aspirin Resistance, Platelet Turnover, and Diabetic Angiopathy: A 2011 UpdateThrombosis Research, 2012
- Executive Summary: Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- “Aspirin - resistance”? A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease, and therapeutic consequencesVasa, 2011
- Glutamate mediates platelet activation through the AMPA receptorJournal of Experimental Medicine, 2008
- Homocysteine and its Derivatives as Possible Modulators of Neuronal and Non-Neuronal Cell Glutamate Receptors in Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2007
- Mechanisms of homocysteine‐induced atherothrombosisJournal of Thrombosis and Haemostasis, 2005
- Aspirin resistance: definition, mechanisms and clinical read-outsJournal of Thrombosis and Haemostasis, 2003
- Effect of homocysteine on arachidonic acid release in human plateletsEuropean Journal of Clinical Investigation, 2002
- Possible Mechanisms of Aspirin ResistanceJournal of Thrombosis and Thrombolysis, 2002
- Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical SignificanceThrombosis and Haemostasis, 2002